Protamine Sulfate Injection, Solution
Product Images NDC 51662-1414

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Protamine Sulfate (NDC 51662-1414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

Protamine sulfate is a medication that can lead to severe side effects, including low blood pressure, lung problems, and heart issues. The risk factors for such side effects include high doses or overdose, rapid administration, repeated doses, previous use, and current use of certain drugs. Patients with certain allergies, medical conditions, or pre-existing health issues should exercise caution when taking this medication. In case of a severe reaction to protamine sulfate, it is important to have vasopressors and resuscitation equipment available. Additionally, this medication should not be administered to patients who are bleeding without prior use of heparin.*

FDA Label Image

How Supplied (How Supplied)

The text describes different types of Protamine Sulfate Injection, USP with varying strengths and volumes in single dose flip-top vials, packaged differently.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Labeling (Serialized Labeling)

Protamine Sulfate Injection, USP is a sterile, nonpyrogenic, preservative-free solution for intravenous use only. Each vial contains 50 mg of Protamine Sulfate per 5 ml (10 mg per mL). The vial is single-dose and should be discarded if any unused portion remains. The product is characterized by its stability and the absence of particulate matter. The provided contact numbers are (01) 00351662141410 and (21) 98317171171, and the expiry date is 201231.*

FDA Label Image

Vial 1 (Vial 1)

Protamine Sulfate Injection, USP is a solution for intravenous use only and contains 10mg per mL. The concentration of the solution is 50mg per 5mL. Unfortunately, the rest of the text is not available due to discrepancies caused by .*

FDA Label Image

Vial 2 (Vial 2)

FDA Label Image

Vial3 (Vial 3)

FDA Label Image

Vial 4 (Vial 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.